CTSO
Cytosorbents Corp
NASDAQ · Healthcare · Medical - Devices · US
$4.96
+20.68%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- 8.29x
- P/S forward
- 0.35x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- -20.75x
- Price / sales
- 0.42x
- Price / cash flow
- -1.51x
Enterprise value
- Enterprise value
- $37.5M
- EV / sales
- 1.01x
- EV / EBITDA
- -2.69x
- EV / EBIT
- -3.02x
- Market cap
- $15.6M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026